SEC
|
HEGGIE THERESA
|
N/A
|
|
-70K
|
$8.51
|
-$595.70K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
-7K
|
$7.54
|
-$52.78K
|
|
SEC
|
McKee Amy E
|
N/A
|
|
-8.6K
|
$6.32
|
-$54.35K
|
|
SEC
|
SANDERS MACHELLE
|
N/A
|
|
-4.7K
|
$6.00
|
-$28.13K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
-6.7K
|
$6.11
|
-$40.92K
|
|
SEC
|
LEVIN ALAN G
|
N/A
|
|
+7.9K
|
$6.36
|
+$50.00K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+2.5K
|
$6.40
|
+$16.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+5K
|
$6.38
|
+$31.90K
|
|
SEC
|
MILANO VINCENT
|
N/A
|
|
+15K
|
$6.25
|
+$93.75K
|
|
SEC
|
Doyle Anthony
|
Chief Financial Officer
|
|
+36K
|
$5.57
|
+$202.19K
|
|
SEC
|
Thackray Helen M.
|
Chief R&D Officer
|
|
+30K
|
$5.86
|
+$175.80K
|
|
SEC
|
Barnes Alane P
|
Chief Legal Officer
|
|
+5K
|
$5.53
|
+$27.65K
|
|
SEC
|
Galson Steven K
|
N/A
|
|
+22K
|
$5.49
|
+$120.45K
|
|
SEC
|
Gayer Charles K
|
Chief Commercial Officer
|
|
+30K
|
$5.47
|
+$164.10K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+30K
|
$5.55
|
+$166.50K
|
|
SEC
|
SANDERS MACHELLE
|
N/A
|
|
-4K
|
$7.98
|
-$31.92K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
-13K
|
$8.04
|
-$103.44K
|
|
SEC
|
Thackray Helen M.
|
Chief R&D Officer
|
|
-7K
|
$8.29
|
-$58.03K
|
|
SEC
|
LEE KENNETH B JR
|
N/A
|
|
+15K
|
$1.71
|
+$25.65K
|
|
SEC
|
Barnes Alane P
|
Chief Legal Officer
|
|
-4.2K
|
$10.88
|
-$45.42K
|
|
SEC
|
Doyle Anthony
|
Chief Financial Officer
|
|
-5.7K
|
$10.90
|
-$62.13K
|
|
SEC
|
Gayer Charles K
|
Chief Commercial Officer
|
|
-6.1K
|
$10.90
|
-$66.49K
|
|
SEC
|
Jones Michael L
|
Exec. Director, Finance - PAO
|
|
-445
|
$10.90
|
-$4.85K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-14K
|
$10.90
|
-$153.69K
|
|
SEC
|
Thackray Helen M.
|
Chief R&D Officer
|
|
-3.1K
|
$10.89
|
-$34.03K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+421
|
$13.36
|
+$5.62K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.5K
|
$13.36
|
+$20.00K
|
|
SEC
|
LEVIN ALAN G
|
N/A
|
|
+842
|
$13.36
|
+$11.25K
|
|
SEC
|
MILANO VINCENT
|
N/A
|
|
+421
|
$13.36
|
+$5.62K
|
|
SEC
|
Babu Yarlagadda S
|
Chief Discovery Officer
|
|
+68K
|
$4.41
|
+$302.02K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+404
|
$13.90
|
+$5.62K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.4K
|
$13.90
|
+$19.99K
|
|
SEC
|
LEVIN ALAN G
|
N/A
|
|
+809
|
$13.90
|
+$11.25K
|
|
SEC
|
MILANO VINCENT
|
N/A
|
|
+404
|
$13.90
|
+$5.62K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+569
|
$9.31
|
+$5.30K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+2.3K
|
$9.31
|
+$21.19K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+4.2K
|
$9.31
|
+$38.69K
|
|
SEC
|
LEVIN ALAN G
|
N/A
|
|
+1.1K
|
$9.31
|
+$10.59K
|
|
SEC
|
ABERCROMBIE GEORGE B
|
N/A
|
|
-5K
|
$11.04
|
-$55.20K
|
|
SEC
|
Thackray Helen M.
|
Chief R&D Officer
|
|
-7.6K
|
$16.20
|
-$123.12K
|
|
SEC
|
Sheridan William P
|
Chief Medical Officer
|
|
-13K
|
$10.33
|
-$132.61K
|
|
SEC
|
Babu Yarlagadda S
|
Chief Discovery Officer
|
|
-20K
|
$17.16
|
-$343.20K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+301
|
$16.61
|
+$5.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+602
|
$16.61
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.1K
|
$16.61
|
+$18.74K
|
|
SEC
|
LEVIN ALAN G
|
N/A
|
|
+602
|
$16.61
|
+$10.00K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-184K
|
$15.04
|
-$2.77M
|
|
SEC
|
Babu Yarlagadda S
|
Chief Discovery Officer
|
|
+32K
|
$7.17
|
+$228.72K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+414
|
$12.06
|
+$4.99K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+829
|
$12.06
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.6K
|
$12.06
|
+$18.74K
|
|
SEC
|
LEVIN ALAN G
|
N/A
|
|
+829
|
$12.06
|
+$10.00K
|
|
SEC
|
MILANO VINCENT
|
N/A
|
|
+7.5K
|
$12.19
|
+$91.43K
|
|
SEC
|
Doyle Anthony
|
Chief Financial Officer
|
|
+35K
|
$12.48
|
+$440.02K
|
|
SEC
|
LEE KENNETH B JR
|
N/A
|
|
+3K
|
$15.35
|
+$46.05K
|
|
SEC
|
ABERCROMBIE GEORGE B
|
N/A
|
|
-3K
|
$9.10
|
-$27.30K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+314
|
$15.92
|
+$5.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+628
|
$15.92
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.2K
|
$15.92
|
+$18.74K
|
|
SEC
|
LEVIN ALAN G
|
N/A
|
|
+628
|
$15.92
|
+$10.00K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+634
|
$15.77
|
+$10.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+317
|
$15.77
|
+$5.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+317
|
$15.77
|
+$5.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.2K
|
$15.77
|
+$18.73K
|
|
SEC
|
ABERCROMBIE GEORGE B
|
N/A
|
|
-6.7K
|
$13.90
|
-$92.67K
|
|
SEC
|
Barnes Alane P
|
Chief Legal Officer
|
|
+36K
|
$7.59
|
+$272.12K
|
|
SEC
|
ABERCROMBIE GEORGE B
|
N/A
|
|
-7K
|
$12.70
|
-$88.90K
|
|
SEC
|
Jones Michael L
|
Exec. Director, Finance - PAO
|
|
+4.5K
|
$3.51
|
+$15.79K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+927
|
$10.78
|
+$9.99K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+463
|
$10.78
|
+$4.99K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+463
|
$10.78
|
+$4.99K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.7K
|
$10.78
|
+$18.75K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
+28K
|
$6.44
|
+$177.54K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+2K
|
$5.11
|
+$10.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+978
|
$5.11
|
+$5.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+978
|
$5.11
|
+$5.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+3.7K
|
$5.11
|
+$18.75K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+2.4K
|
$4.15
|
+$10.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+1.2K
|
$4.15
|
+$5.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+1.2K
|
$4.15
|
+$5.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+4.5K
|
$4.15
|
+$18.75K
|
|
SEC
|
Doyle Anthony
|
Chief Financial Officer
|
|
+54K
|
$4.08
|
+$220.32K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+1.1K
|
$4.50
|
+$5.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+1.1K
|
$4.50
|
+$5.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+2.2K
|
$4.50
|
+$10.01K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+4.2K
|
$4.50
|
+$18.77K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+1.7K
|
$3.00
|
+$5.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+1.7K
|
$3.00
|
+$5.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+3.3K
|
$3.00
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+6.3K
|
$3.00
|
+$18.75K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+1.8K
|
$2.85
|
+$5.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+1.8K
|
$2.85
|
+$5.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+3.5K
|
$2.85
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+6.6K
|
$2.85
|
+$18.75K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+15K
|
$1.45
|
+$21.75K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
+25K
|
$1.45
|
+$36.25K
|
|
SEC
|
Barnes Alane P
|
Senior VP, Chief Legal Officer
|
|
+20K
|
$1.45
|
+$29.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+5K
|
$1.45
|
+$7.25K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+10K
|
$1.45
|
+$14.50K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+20K
|
$1.45
|
+$29.00K
|
|
SEC
|
LEE KENNETH B JR
|
N/A
|
|
+5K
|
$1.45
|
+$7.25K
|
|
SEC
|
Sniecinski Megan
|
Chief Business Officer
|
|
+45K
|
$1.45
|
+$65.25K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+50K
|
$1.45
|
+$72.50K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+1.7K
|
$2.99
|
+$5.00K
|
|
SEC
|
HEGGIE THERESA
|
N/A
|
|
+1.7K
|
$2.99
|
+$5.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+3.3K
|
$2.99
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+6.3K
|
$2.99
|
+$18.75K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+3K
|
$3.57
|
+$10.71K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-5K
|
$5.61
|
-$28.05K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-2.5K
|
$4.99
|
-$12.48K
|
|
SEC
|
ASELAGE STEVE
|
N/A
|
|
+2K
|
$8.30
|
+$16.60K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
+22K
|
$2.90
|
+$65.21K
|
|
SEC
|
Powell Lynne
|
Senior VP - CCO
|
|
-3K
|
$9.27
|
-$28.24K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-771
|
$8.07
|
-$6.22K
|
|
SEC
|
Barnes Alane P
|
Senior VP, Chief Legal Officer
|
|
-423
|
$8.07
|
-$3.41K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-1.1K
|
$8.07
|
-$8.77K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-785
|
$8.07
|
-$6.33K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-3.6K
|
$8.07
|
-$28.79K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-20K
|
$7.58
|
-$155.30K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.9K
|
$9.45
|
-$37.06K
|
|
SEC
|
Barnes Alane P
|
Senior VP, Chief Legal Officer
|
|
-19K
|
$6.31
|
-$121.72K
|
|
SEC
|
Erck Stanley C
|
N/A
|
|
+8.3K
|
$1.49
|
+$12.42K
|
|
SEC
|
Powell Lynne
|
Senior VP - CCO
|
|
-2.5K
|
$6.41
|
-$15.74K
|
|
SEC
|
Powell Lynne
|
Senior VP - CCO
|
|
-6.2K
|
$6.55
|
-$40.28K
|
|
SEC
|
Powell Lynne
|
Senior VP - CCO
|
|
-1.5K
|
$7.51
|
-$11.60K
|
|
SEC
|
Powell Lynne
|
Senior VP - CCO
|
|
-100
|
$7.50
|
-$750.00
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+1.6K
|
$6.43
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+2.9K
|
$6.43
|
+$18.75K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+70K
|
$1.42
|
+$100.01K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
+9.5K
|
$2.29
|
+$21.75K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
+8.9K
|
$4.05
|
+$35.94K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+2K
|
$4.97
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+3.8K
|
$4.97
|
+$18.75K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
+6.7K
|
$3.26
|
+$21.87K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+14K
|
$4.00
|
+$54.90K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-3.9K
|
$5.59
|
-$21.64K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
-2K
|
$5.59
|
-$10.96K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-4.6K
|
$5.59
|
-$25.87K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-4K
|
$5.59
|
-$22.24K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-9.6K
|
$5.59
|
-$53.57K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-838
|
$4.91
|
-$4.11K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
-459
|
$4.91
|
-$2.25K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-1.2K
|
$4.91
|
-$5.74K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-852
|
$4.91
|
-$4.18K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-2.7K
|
$4.91
|
-$13.34K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+2K
|
$5.08
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+3.7K
|
$5.08
|
+$18.75K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-64K
|
$4.72
|
-$303.54K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+2K
|
$5.10
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+3.7K
|
$5.10
|
+$18.75K
|
|
SEC
|
Cohen Fred E
|
N/A
|
|
+1.9K
|
$5.15
|
+$10.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+1.9K
|
$5.15
|
+$10.00K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.9K
|
$5.15
|
+$10.00K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
+754
|
$4.97
|
+$3.75K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
+24K
|
$4.44
|
+$107.21K
|
|
SEC
|
INGRAM ROBERT ALEXANDER
|
N/A
|
|
+1.6K
|
$6.24
|
+$10.00K
|
|
SEC
|
Cohen Fred E
|
N/A
|
|
+1.6K
|
$6.24
|
+$10.00K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+1.6K
|
$6.24
|
+$10.00K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-5.1K
|
$5.95
|
-$30.24K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
-2.6K
|
$5.95
|
-$15.46K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-5.8K
|
$5.95
|
-$34.28K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-5.2K
|
$5.95
|
-$30.93K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-11K
|
$5.95
|
-$62.90K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-1.6K
|
$6.33
|
-$10.37K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
-1.3K
|
$6.33
|
-$8.11K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-2.1K
|
$6.33
|
-$13.17K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-1.7K
|
$6.33
|
-$10.61K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-8.6K
|
$6.33
|
-$54.41K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.3K
|
$7.45
|
-$24.21K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
-8.4K
|
$4.27
|
-$35.68K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-30K
|
$4.06
|
-$121.80K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
-4M
|
$5.00
|
-$20.23M
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-5.9K
|
$5.18
|
-$30.38K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-15K
|
$4.43
|
-$64.58K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+45K
|
$6.33
|
+$284.85K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+208K
|
$6.43
|
+$1.34M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+88K
|
$6.95
|
+$614.00K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+107K
|
$7.28
|
+$777.50K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+345K
|
$7.28
|
+$2.51M
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.1K
|
$10.86
|
-$33.14K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3K
|
$10.49
|
-$31.47K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.5K
|
$16.50
|
-$57.75K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.8K
|
$16.00
|
-$60.00K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
-3K
|
$15.00
|
-$45.00K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-70K
|
$15.05
|
-$1.06M
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-16K
|
$14.36
|
-$235.15K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-20K
|
$15.02
|
-$300.40K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-6K
|
$12.75
|
-$76.50K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3K
|
$12.00
|
-$36.00K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3K
|
$11.00
|
-$33.00K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-12K
|
$10.16
|
-$122.99K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-37K
|
$10.59
|
-$396.07K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-10K
|
$10.50
|
-$110.20K
|
|
SEC
|
Hutson Nancy J
|
N/A
|
|
+10K
|
$10.27
|
+$102.70K
|
|
SEC
|
Sheridan William P
|
Senior VP - CMO
|
|
-128K
|
$12.36
|
-$1.59M
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-9.5K
|
$12.56
|
-$119.32K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-10K
|
$13.58
|
-$135.80K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.1K
|
$13.00
|
-$40.63K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.1K
|
$12.49
|
-$39.03K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.1K
|
$12.00
|
-$37.50K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3.1K
|
$11.24
|
-$35.13K
|
|
SEC
|
LEE KENNETH B JR
|
N/A
|
|
-13K
|
$12.69
|
-$160.72K
|
|
SEC
|
Babu Yarlagadda S
|
Senior VP - Drug Discovery
|
|
-41K
|
$12.57
|
-$510.87K
|
|
SEC
|
Barnes Alane P
|
VP, General Counsel & Corp Sec
|
|
-41K
|
$12.63
|
-$514.47K
|
|
SEC
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
|
-3K
|
$12.69
|
-$38.07K
|
|
SEC
|
ABERCROMBIE GEORGE B
|
N/A
|
|
+3K
|
$6.19
|
+$18.57K
|
|
SEC
|
Baker Bros. Investments, L.P.
|
N/A
|
|
+1.1M
|
$4.40
|
+$5.00M
|
|
SEC
|
ABERCROMBIE GEORGE B
|
N/A
|
|
+3K
|
$1.23
|
+$3.69K
|
|
SEC
|
Jensen Peder
|
N/A
|
|
+20K
|
$1.51
|
+$30.20K
|
|
SEC
|
Jensen Peder
|
N/A
|
|
+20K
|
$3.18
|
+$63.60K
|
|
SEC
|
SANDERS CHARLES A
|
N/A
|
|
+2K
|
$5.22
|
+$10.44K
|
|
SEC
|
Babu Yarlagadda S
|
VP Drug Discovery
|
|
-837
|
$4.78
|
-$4.00K
|
|
SEC
|
McCullough David
|
VP
|
|
-574
|
$4.78
|
-$2.74K
|
|
SEC
|
Sheridan William P
|
SR VP - CMO
|
|
-956
|
$4.78
|
-$4.57K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
-2.7K
|
$4.78
|
-$13.01K
|
|
SEC
|
Babu Yarlagadda S
|
VP Drug Discovery
|
|
-31K
|
$4.22
|
-$130.45K
|
|
SEC
|
McCullough David
|
VP
|
|
-61K
|
$2.45
|
-$148.53K
|
|
SEC
|
McCullough David
|
VP
|
|
-4.5K
|
$2.85
|
-$12.94K
|
|
SEC
|
Jensen Peder
|
N/A
|
|
+10K
|
$2.75
|
+$27.50K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+10K
|
$2.52
|
+$25.20K
|
|
SEC
|
Jensen Peder
|
N/A
|
|
+10K
|
$3.56
|
+$35.60K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+10K
|
$3.40
|
+$34.00K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-23K
|
$3.39
|
-$76.66K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-2.5K
|
$6.20
|
-$15.50K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-1.3K
|
$6.97
|
-$8.71K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-1.3K
|
$7.68
|
-$9.60K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-39K
|
$8.31
|
-$320.38K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-509
|
$8.26
|
-$4.20K
|
|
SEC
|
Sheridan William P
|
SR VP - CMO
|
|
-19K
|
$8.01
|
-$148.93K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-1.2K
|
$6.96
|
-$8.69K
|
|
SEC
|
HOROVITZ ZOLA P
|
N/A
|
|
-10K
|
$7.22
|
-$72.20K
|
|
SEC
|
Mills Mike
|
Principal Accounting Officer
|
|
-1.5K
|
$7.31
|
-$10.97K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-15K
|
$6.96
|
-$104.40K
|
|
SEC
|
Mills Mike
|
Principal Accounting Officer
|
|
-5.1K
|
$7.05
|
-$36.28K
|
|
SEC
|
SANDERS CHARLES A
|
N/A
|
|
+5K
|
$6.66
|
+$33.30K
|
|
SEC
|
HOROVITZ ZOLA P
|
N/A
|
|
-10K
|
$6.85
|
-$68.50K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
-17K
|
$7.02
|
-$119.53K
|
|
SEC
|
McCullough David
|
VP
|
|
-14K
|
$7.02
|
-$100.18K
|
|
SEC
|
Sheridan William P
|
SR VP - CMO
|
|
-4.2K
|
$8.05
|
-$33.54K
|
|
SEC
|
FEATHERINGILL WILLIAM W
|
N/A
|
|
-147K
|
$8.06
|
-$1.19M
|
|
SEC
|
Sheridan William P
|
SR VP - CMO
|
|
-4.2K
|
$8.17
|
-$34.04K
|
|
SEC
|
FEATHERINGILL WILLIAM W
|
N/A
|
|
-14K
|
$9.56
|
-$131.93K
|
|
SEC
|
FEATHERINGILL WILLIAM W
|
N/A
|
|
-439K
|
$9.65
|
-$4.24M
|
|
SEC
|
Babu Yarlagadda S
|
VP Drug Discovery
|
|
-6.4K
|
$10.85
|
-$69.44K
|
|
SEC
|
Babu Yarlagadda S
|
VP Drug Discovery
|
|
-3.4K
|
$10.00
|
-$34.00K
|
|
SEC
|
Sheridan William P
|
SR VP - CMO
|
|
-6K
|
$8.92
|
-$53.52K
|
|
SEC
|
Babu Yarlagadda S
|
VP Drug Discovery
|
|
-20K
|
$9.14
|
-$182.80K
|
|
SEC
|
Mills Mike
|
Principal Accounting Officer
|
|
-1.5K
|
$8.26
|
-$12.39K
|
|
SEC
|
Mills Mike
|
Principal Accounting Officer
|
|
-968
|
$6.00
|
-$5.81K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
-817K
|
$4.22
|
-$3.45M
|
|
SEC
|
Erck Stanley C
|
N/A
|
|
+40K
|
$1.22
|
+$48.80K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
+3K
|
$1.62
|
+$4.86K
|
|
SEC
|
Sheridan William P
|
SR VP - CMO
|
|
+3K
|
$1.62
|
+$4.86K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+3K
|
$1.62
|
+$4.86K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+55K
|
$1.48
|
+$81.40K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+462K
|
$0.99
|
+$457.66K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+25K
|
$1.75
|
+$43.75K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+2.3K
|
$3.10
|
+$7.13K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+7.7K
|
$2.95
|
+$22.72K
|
|
SEC
|
Grant Stuart
|
SR VP & CFO
|
|
+3K
|
$2.82
|
+$8.46K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+240
|
$2.82
|
+$676.80
|
|
SEC
|
DARWIN MICHAEL A
|
Principal Accounting Officer
|
|
+1.7K
|
$2.82
|
+$4.82K
|
|
SEC
|
DARWIN MICHAEL A
|
Principal Accounting Officer
|
|
+1.3K
|
$3.50
|
+$4.69K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+3K
|
$3.50
|
+$10.50K
|
|
SEC
|
BENNETT J CLAUDE
|
Chief Operating Officer
|
|
-20K
|
$12.00
|
-$240.00K
|
|
SEC
|
Stonehouse Jon P
|
President & CEO
|
|
+9.9K
|
$9.90
|
+$98.01K
|
|
SEC
|
FEATHERINGILL WILLIAM W
|
N/A
|
|
+832K
|
$7.80
|
+$6.49M
|
|
SEC
|
ALEXANDER W JAMES
|
SR. VP, Chief Medical Officer
|
|
+2.4K
|
$7.06
|
+$16.76K
|
|
SEC
|
Nugent Jonathan M
|
VP Corp Communications
|
|
+285
|
$7.06
|
+$2.01K
|
|
SEC
|
Stonehouse Jon P
|
CEO
|
|
+2.5K
|
$7.06
|
+$17.39K
|
|
SEC
|
Nugent Jonathan M
|
VP Corp Communications
|
|
+223
|
$8.64
|
+$1.93K
|
|
SEC
|
RIGGS RANDALL B
|
Senior VP Business Development
|
|
+1.2K
|
$8.64
|
+$10.23K
|
|
SEC
|
Nugent Jonathan M
|
VP Corp Communications
|
|
-5.6K
|
$10.19
|
-$57.06K
|
|
SEC
|
ALEXANDER W JAMES
|
SR. VP, Chief Medical Officer
|
|
+1.3K
|
$9.00
|
+$11.57K
|
|
SEC
|
RIGGS RANDALL B
|
Senior VP Business Development
|
|
+744
|
$9.69
|
+$7.21K
|
|
SEC
|
BENNETT J CLAUDE
|
President
|
|
+6.6K
|
$6.50
|
+$42.66K
|
|
SEC
|
BENNETT J CLAUDE
|
President
|
|
+8.8K
|
$10.20
|
+$89.32K
|
|
SEC
|
SEIDENBERG BETH C
|
N/A
|
|
+3K
|
$15.34
|
+$46.02K
|
|
SEC
|
BENNETT J CLAUDE
|
President
|
|
-10K
|
$18.02
|
-$180.20K
|
|
SEC
|
DARWIN MICHAEL A
|
Chief Financial Officer
|
|
-23K
|
$19.21
|
-$435.11K
|
|
SEC
|
BENNETT J CLAUDE
|
President
|
|
-10K
|
$21.00
|
-$210.00K
|
|
SEC
|
BUGG CHARLES E
|
Chairman
|
|
-50K
|
$20.64
|
-$1.03M
|
|
SEC
|
RIGGS RANDALL B
|
Senior VP Business Development
|
|
-1.5K
|
$20.38
|
-$30.81K
|
|
SEC
|
BENNETT J CLAUDE
|
President
|
|
-3K
|
$16.94
|
-$50.82K
|
|
SEC
|
FEATHERINGILL WILLIAM W
|
N/A
|
|
-16K
|
$16.49
|
-$267.14K
|
|
SEC
|
GORDON CARL L
|
N/A
|
|
-567K
|
$14.68
|
-$8.32M
|
|
SEC
|
BUGG CHARLES E
|
CEO, Chairman
|
|
-95K
|
$10.00
|
-$950.00K
|
|
SEC
|
BUGG CHARLES E
|
CEO
|
|
-85K
|
$9.51
|
-$808.35K
|
|
SEC
|
DARWIN MICHAEL A
|
CFO
|
|
-5.7K
|
$8.06
|
-$45.54K
|
|
SEC
|
HOROVITZ ZOLA P
|
N/A
|
|
-22K
|
$8.30
|
-$182.60K
|
|
SEC
|
MONTGOMERY JOHN A
|
N/A
|
|
-40K
|
$8.50
|
-$340.00K
|
|
SEC
|
BVF INC/IL
|
N/A
|
|
-746K
|
$8.00
|
-$5.97M
|
|
SEC
|
SHERRILL JOSEPH H JR
|
N/A
|
|
+7.7K
|
$4.75
|
+$36.58K
|
|
SEC
|
SHERRILL JOSEPH H JR
|
N/A
|
|
+2.1K
|
$4.05
|
+$8.51K
|
|
SEC
|
SHERRILL JOSEPH H JR
|
N/A
|
|
+3.6K
|
$3.99
|
+$14.36K
|
|
SEC
|
FEATHERINGILL WILLIAM W
|
N/A
|
|
+11K
|
$9.00
|
+$99.00K
|
|